导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.65% | 2226/4773 |
| 近一周 | -1.72% | 2648/5465 |
| 近一月 | 2.78% | 187/5421 |
| 近一季 | 3.31% | 473/5231 |
| 近半年 | -2.11% | 2014/4920 |
| 近一年 | 0.40% | 2705/4394 |
| 近两年 | 22.51% | 2600/2954 |
| 近三年 | 21.22% | 1440/2253 |
| 成立以来 | 116.85% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.03% 1089/4961 |
-10.76% 4174/5312 |
- - |
- - |
| 2025 | 3.87% 3087/4813 |
-0.97% 2498/3635 |
6.18% 481/4076 |
-3.45% 3993/4524 |
2.31% 1004/4813 |
| 2024 | 20.58% 456/3463 |
9.88% 106/2808 |
3.75% 251/3014 |
6.13% 2869/3129 |
-0.33% 1388/3463 |
| 2023 | 10.30% 99/2656 |
8.18% 486/2280 |
2.02% 180/2385 |
3.97% 164/2515 |
-3.87% 811/2655 |
| 2022 | 3.07% 23/2207 |
5.16% 38/1919 |
1.42% 1479/2016 |
-1.47% 24/2113 |
-1.92% 1758/2208 |
| 2021 | 24.75% 118/1822 |
7.75% 69/1255 |
7.64% 675/1330 |
10.46% 122/1466 |
-2.62% 1414/1822 |
| 2020 | 13.78% 801/1250 |
-10.51% 785/1028 |
7.52% 839/1067 |
14.23% 291/1164 |
3.52% 909/1184 |
| 2019 | 21.27% 652/1092 |
17.48% 656/754 |
-4.19% 422/804 |
-1.57% 667/850 |
9.45% 226/918 |
| 2018 | - - |
- - |
- - |
- - |
-7.25% 59/691 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 创金合信中证红利低波动指数C VS. 长安沪深300非周期A(740101) |